KPP Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$243K Sell
4,213
-122
-3% -$7K 0.03% 331
2026
Q1
$263K Buy
4,335
+22
+0.5% +$1.28K 0.04% 301
2025
Q4
$233K Sell
4,313
-2,160
-33% -$104K 0.03% 303
2025
Q3
$292K Sell
6,473
-21
-0.3% -$981 0.04% 277
2025
Q2
$301K Sell
6,494
-84
-1% -$4.12K 0.05% 255
2025
Q1
$401K Sell
6,578
-43
-0.6% -$2.51K 0.08% 204
2024
Q4
$374K Sell
6,621
-264
-4% -$14.8K 0.09% 166
2024
Q3
$356K Sell
6,885
-480
-7% -$22.5K 0.09% 175
2024
Q2
$306K Sell
7,365
-569
-7% -$25.5K 0.08% 182
2024
Q1
$430K Sell
7,934
-527
-6% -$26.8K 0.12% 139
2023
Q4
$434K Sell
8,461
-1,567
-16% -$82.3K 0.38% 66
2023
Q3
$582K Buy
+10,028
New +$614K 0.19% 98

Other funds holding BMY

KPP Advisory Services's BMY Position: Q2 2026 in Review

KPP Advisory Services reduced its Bristol-Myers Squibb (BMY) stake by 2.8% in Q2 2026, selling an estimated $7K and leaving 4,213 shares worth $243K. The position accounts for 0.03% of the portfolio, ranked #331.

KPP Advisory Services first reported a position in BMY in Q3 2023 and has held it in 12 quarters since. The position peaked at $582K in Q3 2023. 829 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • KPP Advisory Services held 4,213 shares of Bristol-Myers Squibb worth $243K as of Q2 2026.
  • KPP Advisory Services sold 122 Bristol-Myers Squibb shares in Q2 2026, an estimated $7K.
  • Bristol-Myers Squibb made up 0.03% of KPP Advisory Services's portfolio in Q2 2026, its #331 holding.
  • KPP Advisory Services first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 12 quarters since.
  • KPP Advisory Services's Bristol-Myers Squibb position peaked at $582K in Q3 2023.
  • 829 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on KPP Advisory Services's 13F filing for Q2 2026, filed 24 Jul 2026.